Aktana Launches Next Generation of its Contextual Intelligence Engine to Accelerate Enterprise-Wide AI Adoption
New Engine Integrates All Sources of Insight and Uses Transparent AI to Overcome Barriers to Scale
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced its Contextual Intelligence Engine (CIE) 2.0. The upgraded version of the CIE is designed specifically for two of the most urgent needs in life sciences commercial operations today: omnichannel optimization and AI flexibility. Contextual Intelligence Engine 2.0 can work with any number of analytical models simultaneously to find the best combination of all possible activities, in all channels, by all members of the commercial team.
Users receive intuitive guidance to coordinate personalized experiences for healthcare professionals (HCPs) accompanied by relevant context on the logic behind each suggestion and the most recent omnichannel engagement with that HCP. In addition to end-user outputs, management users can analyze outputs across all channels (both personal and non-personal) to understand what trade-offs the CIE is making.
“Our customers have invested heavily in advanced analytics and new promotional channels over the last 18 months, but have almost universally told us that they're struggling to pull these investments together in a strategic, harmonious way,” said Matthew van Wingerden, vice president of product management at Aktana. “With CIE 2.0, organizations can bring together all of their data and insights—whether it be a dynamic audience selection model developed in-house, AI-derived HCP engagement preferences from Aktana, or any number of other inputs—to transparently solve for maximum commercial impact.”
The challenge of integrating the many sources of insight within an organization, coupled with the “black box” nature of many next best action solutions, has hindered the adoption and scalability of AI in commercial life sciences. CIE 2.0 removes these limitations with a modular architecture, transparency around every recommendation, and a dynamic approach that filters AI-driven suggestions with expert guidance to ensure outputs make sense in the real world.
“Aktana’s approach of working at the pace and scale of our business has allowed us to implement solutions that have immediate value,” says Greg Carpenter of Sanofi. “Our partnership has allowed me to demonstrate that digital transformation is possible when you work with a team like Aktana that has experience delivering advanced analytic solutions but also prioritizes the specific needs of their customers versus simply selling technology.”
Learn more at Aktana’s upcoming webinar on November 10th, 2021. Details to follow on aktana.com.
Aktana is the category creator and leader of intelligent engagement in the global life sciences industry. By ensuring that every customer experience is tailored to individual preferences and needs, Aktana helps life science companies strengthen their relationships with healthcare providers to inspire better patient care. Today, commercial and medical teams from nearly 300 brands use Aktana’s AI-enabled Contextual Intelligence Engine to coordinate and optimize personalized omnichannel engagement at scale. More than half of the top-20 global pharmaceutical companies are Aktana customers. Headquartered in San Francisco, Aktana has offices in every major biopharma region around the world. For more information, visit www.aktana.com.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Result of Riksbank´s purchases of Commercial Paper20.10.2021 10:00:00 CEST | Press release
AuctionAuction resultsAuction date2021-10-20Settlement date2021-10-22Credit rating class1Term3mFixed purchase rate, %0.3Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0 AuctionAuction resultsAuction date2021-10-20Settlement date2021-10-22Credit rating class1Term6mFixed purchase rate, %0.4Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0 AuctionAuction resultsAuction date2021-10-20Settlement date2021-10-22Credit rating class2Term3mFixed purchase rate, %0.6Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0 AuctionAuction resultsAuction date2021-10-20Settlement date2021-10-22Credit rating class2Term6mFixed purchase rate, %0.7Total bid amount, SEK mln0Accepted volume, SEK mln0Percentage alloted, %0Number of bids0
Talenom Plc will publish its Business Review for January-September 2021 on Monday 1 November 2021 at 13:30 EET20.10.2021 09:45:00 CEST | Press release
Talenom Plc, Press release 20 October 2020 at 10:45 EEST Talenom Plc will publish its Business Review for January-September 2021 on Monday 1November 2021 at 13:30 EET Talenom Plc will publish its Business Review for January-September 2021 on Monday 1 November 2021 at 13:30 EET. The company’s CEO Otto-Pekka Huhtala will present the highlights of the Review for analysts, investors and media in Finnish, followed by CFO Antti Aho’s presentation in English as a live webcast that will be held on Monday 1 November 2021 at 14:00 EET. You can watch the webcast online at https://talenom.videosync.fi/q3-2021. The presentation materials will be published before the start of the briefing on the company’s website at https://sijoittajat.talenom.fi/en/ The briefing can also be followed at the company’s premises in Sanoma House (address: Töölönlahdenkatu 2, 00100 Helsinki). The registration is required at the latest on 27 October 2021, by email firstname.lastname@example.org or by phone +358 207 525 403. TALENOM
Rovio Entertainment Corp.: ROVIO AND BILLEBEINO TEAM UP FOR A LIMITED-EDITION ANGRY BIRDS CAPSULE COLLECTION20.10.2021 09:30:00 CEST | Press release
Rovio Entertainment Corporation Press release ROVIO AND BILLEBEINO TEAM UP FOR A LIMITED-EDITION ANGRY BIRDS CAPSULE COLLECTION There's a new bird in town! The two Finnish companies, Rovio Entertainment and lifestyle brand Billebeino have collaborated on a new limited-edition Angry Birds capsule collection, in a deal brokered by IMG. The line features the iconic Angry Birds characters and a new exclusive character Bille Bird, based on Billebeino founder and former NHL player Ville Leino. The limited-edition garments land in select retailers and in the Billebeino online store today. The collection will include unisex casual wear and accessories for adults and children. The garments feature designs that combine the iconic Angry Birds characters with the minimalist and instantly recognizable logo and typeface styles that Billebeino has come to be known for. The aforementioned Bille Bird will appear in graphical placements that play on the fun and destructive nature of the Angry Birds, wit
PubMatic and Semasio Expand Partnership and Deliver Increased Reach for Omnicom Media Group20.10.2021 09:00:00 CEST | Press release
By activating Semasio’s audience segments within PubMatic’s Audience Encore, OMD Netherlands and OMG Germany engaged more consumers compared to DSP activation LONDON, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Today, PubMatic, a sell-side platform that delivers superior outcomes for digital advertising, and Semasio, a pioneer in Unified Targeting which seamlessly combines audience and contextual targeting on the buy- and the sell-side, announced an expanded partnership that enables media buyers to increase audience addressability at a user- and page-level. Semasio’s audience and contextual segments can now be activated directly in PubMatic’s sell-side platform (SSP) for rapid, precision targeting. With the prevalence of third-party cookies continuing to decline and consumer privacy paramount, it is important for agencies to re-define audience addressability strategies to optimise reach. A common concern when targeting data segments is the risk of suboptimal reach due to poor cookie match rates.
Nexstim Plc Business and Clinical Update Q3 202120.10.2021 09:00:00 CEST | Press release
Press release,Helsinki, 20 October 2021 at10:00 AM (EEST) Nexstim Plc Business and Clinical Update Q3 2021 Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the key highlights of the Company’s business and clinical progress during Q3 2021. CEO Mikko Karvinen’sBusiness and Clinical Update I’m very happy to inform that following the strongest first half in the history of the company, our operational business has continued to show positive progress during the third quarter of the year. We have continued to focus on the growth of our Diagnostics Business (NBS) and Therapy Business (NBT®) new system sales in both of our key markets in the United States and Europe. At the same time, we have seen interest in our existing NBS and NBT® System customer base for system upgrades and continued to increase the utilisation rate of our installed base to a record level. This has led into steadily growing recurring revenue levels, which creates stability and a new kind of predictabil
Nexstim Abp:s uppdatering om verksamheten och kliniska framstegen tredje kvartalet 202120.10.2021 09:00:00 CEST | Pressemelding
Pressmeddelande, Helsingfors, 20 oktober 2021 kl. 10.00(EEST) Nexstim Abp:s uppdatering om verksamheten och kliniska framstegen tredje kvartalet 2021 Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”) redogör för de viktigaste händelserna i bolagets verksamhet och kliniska framsteg tredje kvartalet 2021. Vd Mikko Karvinens synpunkter på affärsverksamheten och kliniska framstegen Det gläder mig att kunna berätta att bolaget efter det starkaste halvåret i dess historia har haft fortsatt positiv tillväxt inom affärsverksamheten under tredje kvartalet. Vi har fortsatt att satsa på att öka försäljningen av nya system inom diagnostikverksamheten (NBS) och terapiverksamheten (NBT®) på bägge två av våra huvudmarknader, nämligen USA och Europa. Samtidigt har befintliga kunder för NBS och NBT® uppvisat ett intresse för systemuppgraderingar, vilket har bidragit till en rekordhög användningsfrekvens av den installerade basen. Som en följd har de återkommande intäkterna ökat, vilket ger
Yara reports improved returns20.10.2021 08:00:00 CEST | Press release
Oslo, 20 October 2021:Yara delivers improved returns reflectinghigher prices in third quarter.Net income was a negative USD 143 million, compared with a positive USD 340 million a year earlier. The negative net income includesa USD 355 million impairment ofSalitre assetsin line with Yara’sregulatory release dated1 August 2021,and a currency translation loss of USD 148 million. Excluding currency effects and special items, the basic earnings per share was USD 1.33 compared with USD 0.88 per share in third quarter 2020. The main elements of the third-quarter results are: Improved returns reflecting higher prices8.3% ROIC1, up from 7.9% a year earlier40% ammonia curtailment in Europe due to natural gas price spike “Yara delivers solid third quarter results, with EBITDA2 excluding special items up 37%, mainly thanks to improved margins. However, the gas price spike in Europe has led to Yara curtailing around 40% of its European ammonia production,” said Svein Tore Holsether, President and